#BioLife_Solutions

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

BioLife Solutions Achieves Significant Revenue Growth in 2025 Financial Results BioLife Solutions reported impressive gains in its financial metrics for 2025, highlighting a strong performance in revenue and market expansion for cell and gene therapy.

BioLife Solutions Achieves Significant Revenue Growth in 2025 Financial Results #United_States #gene_therapy #Market_Expansion #BioLife_Solutions #Bothell

Thiard News@F4F

@newsen.bsky.social

1 month ago

BioLife Solutions Partners with Qkine to Enhance Cytokine Offerings in the Gene Therapy Sector BioLife Solutions has entered a multi-year agreement with Qkine to expand its cytokines product portfolio, catering to the growing gene therapy market. This partnership marks a strategic enhancement.

BioLife Solutions Partners with Qkine to Enhance Cytokine Offerings in the Gene Therapy Sector #USA #BioLife_Solutions #Bothell #Qkine_Limited #Cytokines_Market

Thiard News@F4F

@newsen.bsky.social

3 months ago

BioLife Solutions Launches New Center Dedicated to Biopreservation Advancements BioLife Solutions has opened the Aby J. Mathew Center for Biopreservation Excellence, aiming to enhance biopreservation practices and innovations in cell processing.

BioLife Solutions Launches New Center Dedicated to Biopreservation Advancements #United_States #BioLife_Solutions #Bothell #biopreservation #Aby_J._Mathew

Thiard News@F4F

@newsen.bsky.social

3 months ago

BioLife Solutions Set to Showcase Innovations at November and December Investor Conferences BioLife Solutions, a leader in bioproduction for cell and gene therapy, announces key participation in upcoming investor conferences this winter.

BioLife Solutions Set to Showcase Innovations at November and December Investor Conferences #USA #Investor_Conferences #gene_therapy #BioLife_Solutions #Bothell

Thiard News@F4F

@newsen.bsky.social

4 months ago

BioLife Solutions Announces Robust Financial Performance in Q3 2025 Amid Expansion Plans In its latest financial report, BioLife Solutions showcased impressive growth in cell processing revenue and adjusted EBITDA, signaling a strong market position and future potential.

BioLife Solutions Announces Robust Financial Performance in Q3 2025 Amid Expansion Plans #USA #financial_results #BioLife_Solutions #Bothell #cell_processing

Thiard News@F4F

@newsen.bsky.social

5 months ago

Peli BioThermal Fuels Growth with Acquisition of Evo for Enhanced Cold Chain Solutions Peli BioThermal has acquired Evo from BioLife Solutions, enhancing its cold chain logistics and revolutionizing transport solutions, particularly in gene therapy.

Peli BioThermal Fuels Growth with Acquisition of Evo for Enhanced Cold Chain Solutions #USA #BioLife_Solutions #Maple_Grove #Peli_BioThermal #Evo

Thiard News@F4F

@newsen.bsky.social

5 months ago

BioLife Solutions Finalizes Sale of evo Cold Chain Logistics Subsidiary BioLife Solutions has announced the sale of its evo cold chain logistics subsidiary for $25.5 million. This decision aims to streamline operations and enhance shareholder value.

BioLife Solutions Finalizes Sale of evo Cold Chain Logistics Subsidiary #USA #BioLife_Solutions #Bothell #Cold_Chain_Logistics #SAVSU

Thiard News@F4F

@newsen.bsky.social

7 months ago

BioLife Solutions Sees Significant Growth in Q2 2025 Financial Results Amid Expanded Market Presence BioLife Solutions reported impressive Q2 2025 financial results, showcasing a 28% increase in cell processing revenue and significant market expansion.

BioLife Solutions Sees Significant Growth in Q2 2025 Financial Results Amid Expanded Market Presence #USA #BioLife_Solutions #Bothell #Cell_Therapy #Bioprocessing

Thiard News@F4F

@newsen.bsky.social

7 months ago

BioLife Solutions Invests in Pluristyx to Strengthen Cell Therapy Development BioLife Solutions invests $2 million in Pluristyx, supporting stem cell therapy advancements. This strategic move sets the stage for innovation in biological assays.

BioLife Solutions Invests in Pluristyx to Strengthen Cell Therapy Development #USA #BioLife_Solutions #Bothell #Cell_Therapy #Pluristyx

Thiard News@F4F

@newsen.bsky.social

10 months ago

BioLife Solutions Announces Participation in Investor Conferences for 2025 BioLife Solutions, a key player in bioproduction services for cell and gene therapy, will join several investor conferences in late May and June 2025.

BioLife Solutions Announces Participation in Investor Conferences for 2025 #USA #Investor_Conferences #BioLife_Solutions #Bothell #Bioproduction

Thiard News@F4F

@newsen.bsky.social

10 months ago

BioLife Solutions Achieves Significant Growth in Q1 2025 Financial Results BioLife Solutions reports a strong start to 2025, with notable revenue growth and strategic acquisitions in the cell and gene therapy market.

BioLife Solutions Achieves Significant Growth in Q1 2025 Financial Results #United_States #BioLife_Solutions #Bothell #cell_processing #CGT_Market

Thiard News@F4F

@newsen.bsky.social

11 months ago

BioLife Solutions Expands Its Portfolio with the Acquisition of PanTHERA CryoSolutions BioLife Solutions has acquired PanTHERA CryoSolutions, enhancing its leadership in biopreservation with new Ice Recrystallization Inhibitor technology.

BioLife Solutions Expands Its Portfolio with the Acquisition of PanTHERA CryoSolutions #USA #BioLife_Solutions #Bothell #PANthera_CryoSolutions #Cryopreservation

Thiard News@F4F

@newsen.bsky.social

11 months ago

Cathy Coste Joins BioLife Solutions Board Amid Strategic Transition Cathy Coste has been appointed as a director and audit committee chair at BioLife Solutions, marking a significant step in the company's evolving strategy.

Cathy Coste Joins BioLife Solutions Board Amid Strategic Transition #United_States #Board_of_Directors #BioLife_Solutions #Bothell #Cathy_Coste

Thiard News@F4F

@newsen.bsky.social

1 year ago

BioLife Solutions Unveils Impressive Fourth Quarter and 2024 Full Year Earnings Report BioLife Solutions has showcased a strong performance in their latest financial report, highlighting significant growth in cell processing revenue and optimistic projections for 2025.

BioLife Solutions Unveils Impressive Fourth Quarter and 2024 Full Year Earnings Report #USA #BioLife_Solutions #Bothell #cell_processing #CGT_Market

Thiard News@F4F

@newsen.bsky.social

1 year ago

BioLife Solutions Reports Significant Revenue Growth in 2024 with Focus on Cell Therapy Market BioLife Solutions has reported impressive revenue growth in 2024, focusing on the cell and gene therapy market, exceeding expectations in financial performance.

BioLife Solutions Reports Significant Revenue Growth in 2024 with Focus on Cell Therapy Market #USA #BioLife_Solutions #Bothell #cell_processing #biopreservation

Thiard News@F4F

@newsen.bsky.social

1 year ago

BioLife Solutions Welcomes Tony J. Hunt to Its Board of Directors for Enhanced Growth Strategy BioLife Solutions announces the appointment of Tony J. Hunt as a director, enhancing its leadership team amid growth strategies in the CGT sector.

BioLife Solutions Welcomes Tony J. Hunt to Its Board of Directors for Enhanced Growth Strategy #USA #BioLife_Solutions #Tony_Hunt #Repligen_Corporation #Bothell